Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2024

Aug 7, 2024

30016_dirs_2024-08-07_ae61900a-97e4-4bc6-abe4-06e4aaa62275.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-08-05

Reporting Person: MCKEON BRIAN P (EVP, CFO and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-05 Common Stock M 192 Acquired 31048.5926 Direct
2024-08-05 Common Stock F 117 $455.08 Disposed 30931.5926 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-05 Restricted Stock Unit $ M 192 Disposed Common Stock (192) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 18050 Indirect

Footnotes

F1: (1) Includes a total of 22 shares purchased under the Issuer's Employee Stock Purchase Plan on March 29, 2024 and June 28, 2024.

F2: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning August 5, 2020.

F3: Not applicable